This site is intended for healthcare professionals only
This site is intended for healthcare professionals only
Test your clinical skills. This activity will immerse you in a series of interactive clinical situations on managing castration-sensitive prostate cancer (CSPC). You will make decisions, and receive conversational, personalized coaching by a virtual expert at each decision point. This virtual practice will help enable you to recognize and deploy the nuanced patterns of optimal decision-making in managing CSPC.
The goal of this virtually simulated case-based activity is to educate physicians on how to identify the different prostate cancer disease states in a castration-sensitive prostate cancer (CSPC) setting, manage patients who experience biochemical recurrence, and approach risk assessment in patients with CSPC.
Physicians maximum AMA PRA Category 1 Credit™ available: 1.0
Valid for credit through: January 19, 2023
Supported by an independent educational grant from Astellas and Pfizer, Inc.
Rahul Aggarwal, MD
UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, CA
Disclosures: Dr. Aggarwal discloses honorarium from Clovis Oncology; consulting/advisory board for Advanced Accelerator Applications, AstraZeneca, Axiom Biotechnologies, Clovis Oncology, Dendreon; and institutional research support from Abbvie, Amgen, AstraZeneca, BioXcel Therapeutics, Cancer Targeted Technology, Janssen, Merck, Novartis, Xynomic Pharma, Zenith Epigenetics.
Andrew Armstrong, MD
Duke Cancer Institute Durham, NC
Disclosures: Dr. Armstrong discloses consulting/advisory board for Astellas, AstraZeneca, Bayer, Beigene, BMS, Constellation, Dendreon, Forma, Genentech/Roche, Janssen, Merck, Pfizer.
Simpa Salami, MD
University of Michigan Ann Arbor, MI
Disclosures: Dr. Salami discloses Study Advisory Committee for Bayer Pharma.
In support of improving patient care, this activity has been planned and implemented by HMP Education, Springer Healthcare, and Syandus. HMP Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
HMP Education designates this internet enduring activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
HMP Education and Springer Healthcare, LLC, require everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as financial relationships in any amount, occurring within the past 24 months, that could create a conflict of interest.
Elizabeth Samander, PhD
Medical Director, Springer Healthcare
Jill Herr, MD
Medical Lead, Syandus, Inc.
Randy Robbin
President, HMP Education, LLC
Greaton Sellers
Associate Director, Accreditation and Compliance, HMP Education, LLC.
HMP Education, LLC staff have disclosed that they have no relevant financial relationships. Syandus, Inc staff have disclosed that they have no relevant financial relationships. Springer Healthcare, LLC staff have disclosed that they have no relevant financial relationships.
This activity is primarily intended for urologists and medical oncologists. The secondary audience for this activity is other members of the healthcare team making treatment decisions regarding patients with castration-sensitive prostate cancer.
After successful completion of this activity, participants should be better able to:
HMP Education designates this internet enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
HMP Education designates this internet enduring activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board. This activity is designed to be completed within one hour; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page.
For questions regarding the content of this activity, contact the accredited provider for this CME activity noted above. For technical assistance, contact us (digital.enquiries@springer.com).
This CME simulation activity is licensed to Springer Healthcare. Copyright © 2022 Syandus Inc and Springer Healthcare. All rights reserved. No part of this simulation activity may be reproduced without written permission from Springer Healthcare and Syandus Inc.
The educational activity presented involves simulated, case-based scenarios. The patients depicted in these scenarios are fictitious and no association with any actual patient, whether living or deceased, is intended or should be inferred. The material presented here does not necessarily reflect the views of Springer Healthcare or any individuals or commercial entities that support companies that support educational programming on medicinematters.com. These materials may include discussion of therapeutic products that have not been approved by the US Food and Drug Administration, off-label uses of approved products, or data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal. Readers should verify all information and data before treating patients or employing any therapies described in this or any educational activity. A qualified healthcare professional should be consulted before using any therapeutic product discussed herein.
Rahul Aggarwal, MD
UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, CA
Disclosures: Dr. Aggarwal discloses honorarium from Clovis Oncology; consulting/advisory board for Advanced Accelerator Applications, AstraZeneca, Axiom Biotechnologies, Clovis Oncology, Dendreon; and institutional research support from Abbvie, Amgen, AstraZeneca, BioXcel Therapeutics, Cancer Targeted Technology, Janssen, Merck, Novartis, Xynomic Pharma, Zenith Epigenetics.
Andrew Armstrong, MD
Duke Cancer Institute Durham, NC
Disclosures: Dr. Armstrong discloses consulting/advisory board for Astellas, AstraZeneca, Bayer, Beigene, BMS, Constellation, Dendreon, Forma, Genentech/Roche, Janssen, Merck, Pfizer.
Simpa Salami, MD
University of Michigan Ann Arbor, MI
Disclosures: Dr. Salami discloses Study Advisory Committee for Bayer Pharma.
In support of improving patient care, this activity has been planned and implemented by HMP Education, Springer Healthcare, and Syandus. HMP Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
HMP Education designates this internet enduring activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
HMP Education and Springer Healthcare, LLC, require everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as financial relationships in any amount, occurring within the past 24 months, that could create a conflict of interest.
Elizabeth Samander, PhD
Medical Director, Springer Healthcare
Jill Herr, MD
Medical Lead, Syandus, Inc.
Randy Robbin
President, HMP Education, LLC
Greaton Sellers
Associate Director, Accreditation and Compliance, HMP Education, LLC.
HMP Education, LLC staff have disclosed that they have no relevant financial relationships. Syandus, Inc staff have disclosed that they have no relevant financial relationships. Springer Healthcare, LLC staff have disclosed that they have no relevant financial relationships.
This activity is primarily intended for urologists and medical oncologists. The secondary audience for this activity is other members of the healthcare team making treatment decisions regarding patients with castration-sensitive prostate cancer.
After successful completion of this activity, participants should be better able to:
HMP Education designates this internet enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
HMP Education designates this internet enduring activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board. This activity is designed to be completed within one hour; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page.
For questions regarding the content of this activity, contact the accredited provider for this CME activity noted above. For technical assistance, contact us (digital.enquiries@springer.com).
This CME simulation activity is licensed to Springer Healthcare. Copyright © 2022 Syandus Inc and Springer Healthcare. All rights reserved. No part of this simulation activity may be reproduced without written permission from Springer Healthcare and Syandus Inc.
The educational activity presented involves simulated, case-based scenarios. The patients depicted in these scenarios are fictitious and no association with any actual patient, whether living or deceased, is intended or should be inferred. The material presented here does not necessarily reflect the views of Springer Healthcare or any individuals or commercial entities that support companies that support educational programming on medicinematters.com. These materials may include discussion of therapeutic products that have not been approved by the US Food and Drug Administration, off-label uses of approved products, or data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal. Readers should verify all information and data before treating patients or employing any therapies described in this or any educational activity. A qualified healthcare professional should be consulted before using any therapeutic product discussed herein.
Know someone who’ll benefit? Share this CME activity with your colleagues.
